EMVision Medical Devices Ltd (EMV.AX)
AUD 1.9
(1.06%)
AUD 1.9
(1.06%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 11.21 Million AUD | 60.89% |
| 2023 | 6.97 Million AUD | 59.92% |
| 2022 | 4.36 Million AUD | 156.66% |
| 2021 | 1.69 Million AUD | 9.5% |
| 2020 | 1.55 Million AUD | 9.69% |
| 2019 | 1.41 Million AUD | 187.1% |
| 2018 | 492.66 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 4.57 Million AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 6.64 Million AUD | 0.0% |
| 2023 Q2 | 4.94 Million AUD | 0.0% |
| 2023 FY | 6.97 Million AUD | 59.92% |
| 2023 Q4 | 2.02 Million AUD | 0.0% |
| 2022 FY | 4.36 Million AUD | 156.66% |
| 2022 Q2 | 3.43 Million AUD | 0.0% |
| 2022 Q4 | 930 Thousand AUD | 0.0% |
| 2021 Q2 | 1.64 Million AUD | 0.0% |
| 2021 FY | 1.69 Million AUD | 9.5% |
| 2021 Q4 | 55.83 Thousand AUD | 0.0% |
| 2020 FY | 1.55 Million AUD | 9.69% |
| 2020 Q4 | 427.35 Thousand AUD | 0.0% |
| 2020 Q2 | 1.12 Million AUD | 0.0% |
| 2019 Q4 | 738.78 Thousand AUD | 0.0% |
| 2019 Q3 | - AUD | -100.0% |
| 2019 Q2 | 675.65 Thousand AUD | 0.0% |
| 2019 FY | 1.41 Million AUD | 187.1% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | 492.66 Thousand AUD | 0.0% |
| 2018 Q1 | - AUD | 0.0% |
| 2018 Q4 | 492.66 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -198.84% |
| Adherium Limited | 840.98 Thousand AUD | -1234.06% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 82.292% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -174.541% |
| Anteris Technologies Ltd | 4.11 Million AUD | -172.902% |
| Control Bionics Limited | 5.12 Million AUD | -118.83% |
| CardieX Limited | 10.9 Million AUD | -2.875% |
| Compumedics Limited | 49.71 Million AUD | 77.435% |
| Cochlear Limited | 2.25 Billion AUD | 99.503% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 28.639% |
| Cyclopharm Limited | 27.13 Million AUD | 58.661% |
| Nova Eye Medical Limited | 23.32 Million AUD | 51.901% |
| HeraMED Limited | 402.89 Thousand AUD | -2684.633% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -1722.578% |
| ImpediMed Limited | 10.31 Million AUD | -8.724% |
| InhaleRx Limited | 1.2 Million AUD | -831.792% |
| LBT Innovations Limited | 1.25 Million AUD | -793.249% |
| Micro-X Limited | 15.22 Million AUD | 26.296% |
| Neurotech International Limited | 1963.00 AUD | -571433.571% |
| OncoSil Medical Limited | 1.56 Million AUD | -616.707% |
| PolyNovo Limited | 103.19 Million AUD | 89.128% |
| Respiri Limited | 456.91 Thousand AUD | -2355.43% |
| SomnoMed Limited | 91.65 Million AUD | 87.759% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -69.146% |
| Uscom Limited | 3.72 Million AUD | -201.038% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | -29.403% |